We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs
News

Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs

Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs
News

Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The evolutionary history of dogs (Canis lupus familiaris), domesticated over 14,000 years ago, includes artificial selection, population bottlenecks, and inbreeding, which has resulted in over 400 genetically distinct breeds. These characteristics provide a model organism with a broad phenotypic assortment of shapes, sizes, and temperaments to address fundamental questions in population genetics, evolution, and variations in their genetic architecture.

DNA structural variation is now recognized as a significant source of genetic diversity, however its complete biological impact remains unclear.

In two recent studies, Roche NimbleGen Comparative Genomic Hybridization (CGH) microarrays were used to perform systematic and genome-wide analysis of DNA copy number variation (CNV) across dog breeds. Results from these landmark studies revealed that the extent of CNVs in the dog genome and their association with known and candidate disease genes is similar to mice and humans.

In the first study, Chen et al. analyzed seven pedigreed (or purebred) dog breeds using a standard NimbleGen Dog CGH Whole-Genome Tiling Array consisting of 385,000 long oligonucleotide probes with a median probe spacing of 4675 bp. This analysis identified many CNVs in linkage disequilibrium with flanking sequence. Cluster analysis showed that CNV regions in dog breeds tend to group according to breed classes and may be associated with breed-specific traits.

In the second study, Nicholas et al. designed a custom NimbleGen CGH array targeting all predicted segmental duplication regions, which are now recognized as “hotspots” for genome copy number variation in humans and other model organisms. Analysis of the public canine genome reference sequence revealed an estimated 4.21% of the genome is comprised of segmental duplications, which overlap 841 genes and are enriched for certain biological functions and transcription factors.

Analysis of a panel of 17 genetically and phenotypically diverse dog breeds and a gray wolf, identified extensive copy number variation that span 429 genes involved in a wide range of biological processes including gene regulation, sensory perception, and immune responses. In total, CNVs were shown to comprise 24 Mb of polymorphic sequence and 20% of the predicted segmental duplications exhibit CNVs.

To date, research on genetic variation in dogs has been largely limited to either single nucleotide polymorphism (SNP) or microsatellite studies. However, the landmark studies described above indicate that DNA copy number variation is a significant source of genetic and phenotypic variation in dogs. The availability of high-resolution maps of CNVs across dog breeds will allow researchers to evaluate the biological significance of breed-specific CNVs and associated candidate disease genes.
Advertisement